Welspun Enterprises cheered investors today with a strong Q3 performance, delivering a 167% growth in operating profit margins YoY, which ramped up net profit growth to 170.9% YoY. Revenue growth is also up, at 49.4% YoY. The company is in ten stock sreeners, including the undervalued growth stocks screener. The stock is up in share price on the news. 

Bliss GVS Pharma, which also announced results today, showed both revenue and net profit growth, but key numbers including EBIDT and margin growth are down. Tata Steel BSL also announced results - this and others are available in the full results dashboard.